Dr Henry Fisher Chief Scientific Officer

Oxford PhD in CNS drug delivery. Started his career at the Beckley Foundation in 2015. Since then Henry has founded three companies over 7 years in the psychedelics and cannabis sectors.

Roles focused on advising clients on R&D strategy, IP generation, and research operations. 

At Clerkenwell Health, Henry has led multiple MHRA meetings and ILAP applications, managed the delivery of regulatory submissions, and advised on Schedule 1 drug license requirements.